News Sentiment

ANNX sentiment intelligence

Annexon Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 56 Balanced news tone 58 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 5.80 Week of 10 Jul 2026
Weighted tone 56/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

82/100 classification confidence.

Company focus 49

directly relevant articles

Source quality 2

high-authority source matches

Trend context Trend inactive

+6.2% over one week, +23.1% over four weeks, trend inactive, and materially above fair value.

Latest direct headline Neutral

How Investors Are Reacting To Annexon (ANNX) Phase 3 Tanruprubart Win And Vonaprument Updates

Market Reaction

Price moving ahead of tone

66/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 82/100 classification
One-week reaction 6.2% Price confirming higher
Trend fit Trend inactive 23.1% over four weeks
Fair value 36.0% Materially above fair value

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 19
Neutral 38
Negative 1

Relevance

Why the article matched

Direct first
Direct company coverage 49
Industry context 9
Sector context 0

Sources

Coverage mix

Publishers
Stock Titan 12
Market source 9
TradingKey 4
GlobeNewswire 3
TradingView 3
Quartr 3
MarketBeat 3
GuruFocus 2

Event Lens

What the news is about

Classified themes
Market update 34
Earnings 15
Analyst action 4
Deals and strategy 3
Balance sheet 1
Capital return 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-30 of 58
Yahoo! Finance Canada Direct company coverage

Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)

Annexon, Inc. (Nasdaq: ANNX) announced inducement grants to two new non-executive employees under the terms of its 2022 Employment Inducement Award Plan. These equity awards, approved on July 12, 2026, consist of options to purchase 335,000 shares of common stock with an exercise

Tone
Positive 62/100
Event
Market update
Published
16 Jul 2026 19:41
Source
Yahoo! Finance Canada
Stock Titan Direct company coverage

Two New Annexon Employees Receive 10-Year Options at $6.50

Annexon (Nasdaq: ANNX) has granted stock options for an aggregate of 335,000 common shares to two new non-executive employees under its 2022 Employment Inducement Award Plan. The options have a ten-year term with an exercise price of $6.50 per share, which was the closing price o

Tone
Neutral 50/100
Event
Market update
Published
16 Jul 2026 19:41
Source
Stock Titan
Stock Titan Direct company coverage

Annexon (ANNX) filer Thomas Wiggans eyes 2,000-share NASDAQ stock sale

Thomas Wiggans, a shareholder in Annexon (ANNX), has filed a notice for the proposed sale of 2,000 common shares via Fidelity Brokerage Services LLC on NASDAQ, with an indicated value of $12,630.01. This planned sale follows a previous sale of 1,000 common shares by Wiggans on Ju

Tone
Neutral 50/100
Event
Market update
Published
15 Jul 2026 20:17
Source
Stock Titan
GuruFocus Direct company coverage

ANNX Maintained by Needham -- Price Target Raised to $25

Needham analyst Joseph Stringer maintained a 'Buy' rating on Annexon (ANNX) and significantly raised the price target from $11.00 to $25.00, reflecting strong confidence in the company's growth potential. Despite a low GF Score of 34/100, primarily due to profitability challenges

Tone
Positive 75/100
Event
Analyst action
Published
15 Jul 2026 12:17
Source
GuruFocus
Investing.com Canada Direct company coverage

Annexon to present data on vonaprument for macular degeneration By Investing.com

Annexon Inc. is set to present Phase 2 ARCHER trial data on its drug candidate, vonaprument, for geographic atrophy at the American Society of Retina Specialists 44th Annual Scientific Meeting. This data will inform patient selection for the ongoing Phase 3 ARCHER II trial, which

Tone
Positive 71/100
Event
Market update
Published
15 Jul 2026 01:12
Source
Investing.com Canada
Investing.com Direct company coverage

Annexon to present data on vonaprument for macular degeneration

Annexon Inc. will present data from its Phase 2 ARCHER trial for vonaprument, a treatment for geographic atrophy, at the American Society of Retina Specialists meeting. The data will help select patients for the ongoing Phase 3 ARCHER II trial, which completed enrollment in July

Tone
Positive 72/100
Event
Market update
Published
14 Jul 2026 20:16
Source
Investing.com
GlobeNewswire Direct company coverage

Annexon to Present Phase 2 ARCHER Baseline Characteristics Associated with Confirmed Best Corrected Visual Acuity 15-Letter Loss in Patients with Geographic Atrophy at ASRS 2026

Annexon, Inc. announced an oral presentation at the American Society of Retina Specialists 44th Annual Scientific Meeting regarding the neuroprotective effect of vonaprument. The presentation will highlight baseline characteristics from the Phase 2 ARCHER trial associated with be

Tone
Positive 75/100
Event
Market update
Published
14 Jul 2026 20:12
Source
GlobeNewswire
Stock Titan Direct company coverage

Annexon to present baseline factors tied to 15-letter vision loss in AMD

Annexon (NASDAQ: ANNX) is set to deliver an oral presentation at the American Society of Retina Specialists (ASRS) 44th Annual Scientific Meeting, detailing Phase 2 ARCHER trial data for vonaprument in dry age-related macular degeneration (AMD) with geographic atrophy (GA). The p

Tone
Positive 62/100
Event
Market update
Published
14 Jul 2026 20:12
Source
Stock Titan
Stock Titan Direct company coverage

[144] Annexon, Inc. SEC Filing

This article details a Form 144 SEC filing by Annexon, Inc. (ANNX), indicating a proposed sale of securities. The filing shows a sale of 1000 common shares by an individual with Fidelity Brokerage Services LLC, acquired through a stock option exercise, with an aggregate market va

Tone
Neutral 50/100
Event
Market update
Published
14 Jul 2026 18:12
Source
Stock Titan
TradingView Direct company coverage

Price to book forward of Annexon, Inc. – NASDAQ:ANNX

This article provides financial information for Annexon, Inc. (NASDAQ: ANNX), specifically focusing on its "Price to book forward" metric. The content appears to be a financial data page from TradingView, displaying the company's stock exchange listing and current market status.

Tone
Neutral 50/100
Event
Market update
Published
11 Jul 2026 01:09
Source
TradingView
Stock Titan Direct company coverage

Redmile Group (ANNX) reports 9.9% stake; RedCo II Offshore at 5.5%

Redmile Group, LLC, and affiliated persons, including Jeremy C. Green, have reported a beneficial ownership stake of 9.9% in Annexon, Inc. (ANNX), comprising 17,918,459 shares. Additionally, RedCo II Offshore SPV LLC disclosed a 5.5% stake with 9,802,458 shares. These figures inc

Tone
Neutral 50/100
Event
Deals and strategy
Published
09 Jul 2026 01:40
Source
Stock Titan
Stock Titan Direct company coverage

FMR LLC reports 11.9% stake in Annexon (NASDAQ: ANNX)

FMR LLC has filed a Schedule 13G/A, disclosing a beneficial ownership of 19,518,496.35 shares of Annexon (NASDAQ: ANNX) common stock, representing an 11.9% stake as of June 30, 2026. This filing indicates a passive investment intent, with FMR LLC holding sole dispositive power ov

Tone
Neutral 50/100
Event
Deals and strategy
Published
08 Jul 2026 14:40
Source
Stock Titan
Quartr Direct company coverage

Annexon (ANNX) Goldman Sachs 47th Annual Global Healthcare Conference 2026 summary

Annexon presented key updates on its clinical programs at the Goldman Sachs 47th Annual Global Healthcare Conference 2026, focusing on vonaprument for geographic atrophy (GA). The company anticipates pivotal Phase III data in Q4 2026, with vision preservation as the primary endpo

Tone
Positive 71/100
Event
Market update
Published
08 Jul 2026 12:11
Source
Quartr
Simply Wall Street Direct company coverage

Does Annexon’s Shift Into Russell Growth Indices Recast Its Core Equity Story for Investors (ANNX)?

Annexon, Inc. (ANNX) recently shifted from Russell value to growth indices in late June 2026, which impacts its perceived style profile and investor exposure. While this reclassification mainly affects who holds the stock, Annexon's core investment narrative remains focused on it

Tone
Neutral 50/100
Event
Market update
Published
08 Jul 2026 11:40
Source
Simply Wall Street
Finviz Direct company coverage

ANNX - Annexon Inc Options

This page provides detailed financial and stock options information for Annexon Inc (ANNX). It includes key metrics such as market capitalization, income, sales, EPS, various financial ratios, insider and institutional ownership, and stock performance data. The data indicates rec

Tone
Positive 59/100
Event
Earnings
Published
06 Jul 2026 23:10
Source
Finviz
www.marketscreener.com Direct company coverage

Annexon, Inc.(NasdaqGS: ANNX) dropped from Russell 2000 Value Benchmark

Annexon, Inc. (NasdaqGS: ANNX) has been removed from the Russell 2000 Value Benchmark. This news follows several recent re-benchmarking announcements, including its addition to the Russell 2500 Growth and Russell 2000 Growth Benchmarks, and also being dropped from the Russell Mic

Tone
Neutral 50/100
Event
Market update
Published
29 Jun 2026 15:09
Source
www.marketscreener.com
TradingView Direct company coverage

Annexon, Inc. Actuals & Estimates (NASDAQ:ANNX)

This article provides an overview of Annexon, Inc. (NASDAQ:ANNX) financial actuals and estimates, including its current stock price, market capitalization, and analyst forecasts. It also covers historical stock performance, earnings reports, and other key financial data. Investor

Tone
Positive 60/100
Event
Earnings
Published
26 Jun 2026 01:10
Source
TradingView
富途牛牛 Direct company coverage

Annexon, Inc.'s (NASDAQ:ANNX) Profit Outlook

This article analyzes the profit outlook for Annexon, Inc. (NASDAQ:ANNX) based on analyst forecasts. It discusses how the company is expected to transition from its current loss-making status to profitability and the projected financial performance over the coming years according

Tone
Positive 58/100
Event
Earnings
Published
24 Jun 2026 19:39
Source
富途牛牛
Quartr Direct company coverage

Annexon (ANNX) Jefferies Global Healthcare Conference 2026 Summary

This article summarizes Annexon's (ANNX) presentation at the Jefferies Global Healthcare Conference 2026, highlighting its strategic focus on pioneering C1q inhibition for neuroinflammatory diseases. Key points include late-stage development programs for Guillain-Barré syndrome (

Tone
Positive 74/100
Event
Market update
Published
22 Jun 2026 17:09
Source
Quartr
Quartr Direct company coverage

Annexon (ANNX) AGM 2026 Summary

Annexon's 2026 AGM summarized highlights from the company's annual meeting on June 11, 2026. Key points included a financial performance review indicating a cash runway into Q2 2027 and updates to the board and executive committee, noting the retirement of Tom Wiggans. The summar

Tone
Positive 72/100
Event
Balance sheet
Published
22 Jun 2026 04:41
Source
Quartr
TradingKey Direct company coverage

Annexon Inc (ANNX) Institutional Confidence

This article examines the institutional confidence in Annexon Inc (ANNX) by detailing the shareholdings and activity of several major institutional investors. It highlights significant changes in holdings by firms like Redmile Group, Alerce Investment Management, and Adage Capita

Tone
Positive 70/100
Event
Market update
Published
18 Jun 2026 02:39
Source
TradingKey
TradingKey Direct company coverage

Annexon Inc (ANNX) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for Annexon Inc (ANNX), including analyst ratings, target prices, and EPS estimates. Based on 11 analysts, the stock has a "Buy" trend with a target price of $14.50, representing an upside of over 220%. The report also includes past and

Tone
Positive 65/100
Event
Earnings
Published
18 Jun 2026 02:36
Source
TradingKey